Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,321 | -8,500 | -4,378 | -14,578 | -9,463 |
| Other Working Capital | 259 | 48 | -14 | 1,140 | 1,321 |
| Other Operating Activity | 2,929 | 2,509 | 1,329 | 3,637 | 2,539 |
| Operating Cash Flow | $-8,133 | $-5,943 | $-3,063 | $-9,801 | $-5,603 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,421 | 4,830 | 4,510 | 8,163 | 3,544 |
| Financing Cash Flow | $6,421 | $4,830 | $4,510 | $8,163 | $3,544 |
| Beginning Cash Position | 7,474 | 7,474 | 7,474 | 9,112 | 9,112 |
| End Cash Position | 5,763 | 6,361 | 8,921 | 7,474 | 7,052 |
| Net Cash Flow | $-1,712 | $-1,113 | $1,447 | $-1,638 | $-2,059 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,133 | -5,943 | -3,063 | -9,801 | -5,603 |
| Free Cash Flow | -8,133 | -5,943 | -3,063 | -9,801 | -5,603 |